PEGylated versus non-PEGylated drugs: A  cross-sectional analysis of adverse events in the FDA Adverse Event Reporting System (FAERS) Database
.

CONCLUSION: The pharmacovigilance profiles of PEGylated and non-PEGylated agents were similar. Further clinical assessment is required to validate the pharmacovigilance data.
. PMID: 32324132 [PubMed - as supplied by publisher]
Source: International Journal of Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Tags: Int J Clin Pharmacol Ther Source Type: research